Media said that the scientist of Sinovac vaccines in Indonesia dies due to suspected infection with the Corona virus
The death of Novelia Sejfri Bakhtiar comes as deaths from the coronavirus have reached record levels in Indonesia, one of the countries where the Sinovac vaccine is widely used.
The Comparan News Service said Novelia died of the coronavirus. Sindonews quoted an official at the state-owned pharmaceutical company BioFarma as saying that she was buried according to Covid-19 protocols.
The Minister for Governmental Institutions, Eric Thohir, posted a message on Instagram mourning the “terrible loss” of BioFarma, which makes the vaccine. The cause of her death was not mentioned.
“She has been a lead scientist and head of dozens of clinical trials conducted by BioFarma, including the clinical trials of the Covid-19 vaccine in collaboration with Sinovac,” he said.
“It has been produced and injected into tens of millions of people in Indonesia, as part of our effort to get rid of this COVID-19 pandemic.”
BioFarma did not immediately respond to a request for comment on the death of Novilia, who was in her early 50s.
Infections and deaths of health workers in Indonesia who received the Sinovac vaccine have added to questions about its effectiveness in preventing hospitalization and death.
According to independent data set Lapor Covid-19, 131 health care workers, most of whom were vaccinated with a Sinovac bullet, have died since June, including 50 in July.
Indonesia recorded more than 1,000 coronavirus deaths in a single day for the first time on Wednesday, with 34,379 infections. The latest wave of infections has been driven by the delta type, which was first identified in India.
Last month, Sinovac spokesman Liu Beisheng told Reuters that preliminary results showed the vaccine produced a threefold reduction in its effect against the delta variant.